• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.

作者信息

Torres Dawn M, Harrison Stephen A

机构信息

Division of Gastroenterology Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD.

出版信息

Hepatology. 2015 May;61(5):1462-4. doi: 10.1002/hep.27680. Epub 2015 Mar 19.

DOI:10.1002/hep.27680
PMID:25564771
Abstract
摘要

相似文献

1
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.非酒精性脂肪性肝病：纤维化预示着更差的预后。
Hepatology. 2015 May;61(5):1462-4. doi: 10.1002/hep.27680. Epub 2015 Mar 19.
2
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.纤维化分期是经过长达 33 年随访后，NAFLD 患者疾病特异性死亡率的最强预测因子。
Hepatology. 2015 May;61(5):1547-54. doi: 10.1002/hep.27368. Epub 2015 Mar 23.
3
The Natural Course of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的自然病程。
Int J Mol Sci. 2016 May 20;17(5):774. doi: 10.3390/ijms17050774.
4
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.酒精性和非酒精性脂肪性肝病对肝脏相关发病率和死亡率负担的贡献。
Gastroenterology. 2016 Jun;150(8):1778-85. doi: 10.1053/j.gastro.2016.03.005. Epub 2016 Mar 12.
5
Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者重复肝脏硬度测量与肝活检的比较。
Hepatol Int. 2018 Jan;12(1):44-55. doi: 10.1007/s12072-018-9843-4. Epub 2018 Jan 25.
6
Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.酒精性或非酒精性脂肪性肝炎所致肝硬化肝移植受者心血管事件的发生率及其对生存的影响
Exp Clin Transplant. 2016 Feb;14(1):79-85. doi: 10.6002/ect.2015.0089. Epub 2015 Nov 17.
7
Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.非酒精性脂肪性肝病中的纤维化：机制与临床意义
Semin Liver Dis. 2015 May;35(2):132-45. doi: 10.1055/s-0035-1550065. Epub 2015 May 14.
8
Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.非酒精性脂肪性肝病：一种疾病，多种肝脏健康影响。
Cell Biol Toxicol. 2017 Feb;33(1):5-14. doi: 10.1007/s10565-016-9361-x. Epub 2016 Sep 28.
9
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.非酒精性脂肪性肝病中的肝纤维化——具有预后意义的诊断挑战
World J Gastroenterol. 2015 Oct 21;21(39):11077-87. doi: 10.3748/wjg.v21.i39.11077.
10
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.非肝硬化非酒精性脂肪性肝病（NAFLD）患者肝细胞癌（HCC）的特征
Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11.

引用本文的文献

1
Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells.肝星状细胞中SOCS1表达对高脂饮食诱导的肝纤维化的调控
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101280. doi: 10.1016/j.jceh.2023.09.001. Epub 2023 Sep 9.
2
Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China.中国 MAFLD 和 NAFLD 患者的心血管和肾脏负担。
Front Endocrinol (Lausanne). 2022 Sep 2;13:968766. doi: 10.3389/fendo.2022.968766. eCollection 2022.
3
Long Noncoding RNA lnc-HC Regulates PPARγ-Mediated Hepatic Lipid Metabolism through miR-130b-3p.
长链非编码RNA lnc-HC通过miR-130b-3p调控PPARγ介导的肝脏脂质代谢。
Mol Ther Nucleic Acids. 2019 Dec 6;18:954-965. doi: 10.1016/j.omtn.2019.10.018. Epub 2019 Oct 25.
4
Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders.无细胞循环核酸作为非酒精性脂肪性肝病及相关疾病的早期生物标志物
Front Physiol. 2018 Sep 20;9:1256. doi: 10.3389/fphys.2018.01256. eCollection 2018.
5
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.ASK1 抑制剂 selonsertib 治疗非酒精性脂肪性肝炎患者的随机、2 期临床试验。
Hepatology. 2018 Feb;67(2):549-559. doi: 10.1002/hep.29514. Epub 2017 Dec 26.
6
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.NLRP3炎性小体阻断可减轻小鼠实验性非酒精性脂肪性肝炎中的肝脏炎症和纤维化。
J Hepatol. 2017 May;66(5):1037-1046. doi: 10.1016/j.jhep.2017.01.022. Epub 2017 Feb 3.
7
[Frontiers of research on nonalcoholic fatty liver disease].[非酒精性脂肪性肝病的研究前沿]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 Jan;45(1):98-101. doi: 10.3785/j.issn.1008-9292.2016.01.16.
8
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.水飞蓟宾-维生素E-磷脂复合物可减轻接受聚乙二醇化干扰素α和利巴韦林治疗的慢性丙型肝炎患者的肝纤维化。
Am J Transl Res. 2015 Nov 15;7(11):2510-8. eCollection 2015.
9
Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins.非酒精性脂肪性肝病生物学中的表观遗传修饰：DNA羟甲基化和TET蛋白的作用
Medicine (Baltimore). 2015 Sep;94(36):e1480. doi: 10.1097/MD.0000000000001480.